Background: Wound care is the cornerstone of treatment for patients with epidermolysis bullosa (EB); however, there are currently no guidelines to help practitioners care for these patients.
determined by the nature of mutations and the gene penetration resulting in different phenotypic expression. 2, 3 In the absence of a cure, supportive wound care and early recognition and treatment of complications are the mainstays of patient treatment.
Wound care in the EB population poses unique challenges: clinical variability requires an individualized management plan; availability of a myriad of wound care products complicates the decision process and there is a high overall cost to the family and health units.
To date, there are no specific wound care guidelines or any evidence that address the wound care challenges of the EB population. The objective of this study was to generate a list of recommendations that will allow practitioners to better manage the complex needs of this population.
METHODS
A group of international experts in the fields of EB, wound care, infectious diseases, and bonemarrow transplantation met for 3 days in Alton, Ontario, Canada, to address wound care in patients with EB (Fig 1) . The 11 attendees (physicians and nurses) were selected based on their EB clinical and research expertise and background in wound care, wound-healing biology, infectious diseases, and bone-marrow transplantation. Attendees were asked to review all the literature that pertained to their area of expertise and present their findings during the meeting. A group discussion ensued that generated a list of recommendations considered essential for enhancing wound healing in patients with EB. Using an online-based modified Delphi method for generating consensus, 4 ,5 the list was translated into a survey that was sent to 33 other international EB experts. The experts were asked to rate each recommendation on a 4-point Likert scale (strongly disagree, slightly disagree, slightly agree, strongly agree). At least an 80% agreement was required for each item to be adopted in the final list of recommendations. (Table I) were generated through plenary discussion and sent for formal consensus. ). Most respondents were physicians (67%), while nursing (17%) and allied health professionals (7%) represented the difference. All items were retained because of a high degree of agreement with the original recommendations ( Table I ). The list was further refined by grouping items into main themes and specific recommendations (Table II) .
RESULTS

Fourteen items
Assess patient ability to heal and treat the cause Recommendation 1: evaluate EB typeespecific involvement. Patients with EB simplex (EBS) present predominantly with acral blisters exacerbated by heat and friction. 6 Blistering can be more extensive in the generalized forms of EBS and recessive forms of EBS with suprabasal cleavage. 6, 7 Dowling-Meara form of EBS is characterized by grouped blisters that extend at the periphery resembling a string of pearls and acral blisters that lead to painful keratoderma. The Herlitz variant of junctional EB has a pathognomonic presentation with periorificial blistering, exuberant hypergranulation tissue, and periungual involvement with nail shedding. The diaper region is often particularly difficult to manage, as large denuded areas are difficult to protect from urine and feces. Scarring and milia formation are a hallmark of dystrophic EB (DEB). The location of the blisters is variable, but tends to affect traumaprone areas. Patients with severe forms of recessive DEB (RDEB) commonly present with chronic wounds (lasting months, sometimes years) affecting large body surface areas. 8 Kindler syndrome is a rare autosomal recessive genodermatosis in which skin fragility early in life is gradually replaced by poikiloderma, scarring, and photosensitivity of the skin. 9 Before deciding on a wound care management strategy it is important to take an inventory of the body surface area affected, and the types of skin involvement (intact blisters, erosions, chronic wounds). Ideal methods of serial assessment of wounds in patients with EB are lacking. In addition, most patients are very reluctant to expose their entire skin surface at each visit. Often the care team needs to negotiate a rotating skin examination schedule
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Wound care management is a mainstay of treating patients with epidermolysis bullosa, but currently there are no available guidelines. We generated 17 specific recommendations that include current evidence on wound care and address patient concerns.
that allows for the entire skin surface to be carefully inspected at least every 6 months. Signs of local infection such as increased redness, local pain, odor, and exudate should be documented for each problematic wound.
Recommendation 2: consider patient age. The patient age is an important consideration when developing a wound care plan. Infants typically require a lot more control of their immediate environment to prevent trauma. 10 This includes, but is not limited to, techniques of gentle handling by the caregivers. Foam dressings are preferred for padding of bony prominences. The diaper area is particularly difficult to manage as it is prone to more physical and chemical trauma. The elastic bands of the diapers should be removed and cleansing wipes avoided. The diaper can be lined with a nonstick dressing or ''buttered'' with a thick layer of zinc oxide paste. As the child becomes more mobile, knee padding and soft special shoes are required to prevent blistering. Older patients tend to have more chronic ulcers that are critically colonized and infected and there is increased likelihood of colonization with antibioticresistant bacteria. Patients with more severe forms of EB are at an increased risk of squamous cell carcinoma (SCC). Although this is an unusual occurrence before the second or third decade of life, 11 it has been described in a 6-year-old child.
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Recommendation 3: assess and manage poor nutritional status. Wound healing can be delayed or interrupted in persons with existing comorbidities. Malnutrition is very common in the severe types of EB, resulting from a combination of reduced intake and increased demands. 13, 14 Malnutrition leads to failure to thrive, delayed puberty, and anemia, a cascade of clinical and biological events, further affecting wound healing and increasing skin breakdown. [15] [16] [17] Low protein intake or relative deficiency can prevent the production of granulation tissue contributing to ''stalled'' healing. 18 Albumin levels, a gross indicator of long-term nutritional deficit, less than 2.0 to 3.0 g/dL (normal: 3.0-5.4 g/dL) 19 are associated with impaired healing. Blood sampling can be difficult as a result of poor venous access, therefore a more practical approach for assessing the overall nutritional status is monitoring of the growth curves in pediatric patients and body mass index in adults with EB. Regular nutritional consults (including calorimetry) to evaluate caloric needs are recommended. To optimize nutritional status, patients with severe forms of EB may require a gastrostomy tube. Supplementation of identified deficiencies is commonly suggested by many EB centers and 6-to 12-month monitoring to identify them is endorsed.
Recommendation 4: monitor and maintain hemoglobin levels above 80 g/L. Anemia, likely multifactorial in nature, 13 is a frequent and serious complication of the severe types of EB such as RDEB and junctional EB. Hemoglobin less than 100 g/L causes impaired wound healing in patients with venous ulcers as a result of decreased tissue oxygenation. 20 Low hemoglobin levels in patients with EB are one of the factors that may contribute to delayed healing. There is no ideal management strategy for dealing with anemia in patients with EB. A pathogenic-based approach is sensible, but not always possible. Adequate skin care and preventing/treating infection can minimize blood losses through the skin. Oral iron supplementation for correction of iron deficiency is widely used but its individual effectiveness varies. Moreover, gastrointestinal upset and constipation are reasons for nonadherence. Intravenous iron 21 plus erythropoietin were beneficial in a small study of patients with RDEB. 22 Blood transfusions should be considered for cases where hemoglobin levels are consistent below 80 g/L and/or for symptomatic patients who do not respond to other measures.
Patient-centered concerns
Recommendation 5: pain assessment and management. Pain is the most common symptom experienced by patients with EB, irrespective of subtype. The frequency and severity of pain is often proportional to disease severity, with up to 50% of patients with the most extensive type of EB (RDEB) experiencing daily pain greater than 5 (0-10 scale). 23 Although the cause of pain in EB is multifactorial, the skin and related EB lesions are by far the most significant source of pain. The pain can occur at rest from blisters and denuded skin, secondary infection, friction, and shearing with physical movements. 24 Pain can also be exacerbated during dressing changes, bathing, and other activities of daily living. Development of a pain management approach requires adequate documentation of pain levels before and after dressing changes, bathing, and other painful interventions. 25 Pain assessments using age-appropriate tools also allow identification of a temporal pattern and aggravating factors. 26, 27 Other patient-related factors (anxiety, depression, past experiences) contributing to the pain experience should be recognized and treated. The approach to pain in a patient with EB includes preventative and therapeutic modalities (Table III) . In general, wound-associated pain is both nociceptive, stimulus-dependent (gnawing, throbbing); and neuropathic, nonstimulus-dependent (burning, stinging, shooting, stabbing). Nociceptive pain is treated with the World Health Organization pain ladder medication (Table III) . 28 Short-acting agents are used to determine the dose of longer-acting agents and for breakthrough pain before painful procedures. Neuropathic pain often responds to tricyclic agents, particularly second-generation agents. For nonresponders, gabapentin, 29 pregabalin, or other antiepileptics may be helpful. Procedural pain requires an interprofessional approach and communication to those within the circle of care. This is especially important for children with EB as they are often subjected to repeated procedures. Oral sucrose 24% is a useful, short-acting analgesic that is effective for children younger than 2 years of age. 30 For older children and adults, acetaminophen or morphine administered 30 minutes before the procedure may be used. Ketamine is another alternative drug that can also be used for 31 Nonpharmacological modalities (Table III) are also helpful in combination with the pharmacological measures listed above. Some potentially useful topical options include adding salt to the bathwater 32 and dressings with analgesics (Biatain-IBU, Coloplast, Humlebaek, Denmark).
Recommendation 6: control itch. Itch is a common symptom in the EB population, often poorly controlled, affecting quality of life. The exact mechanism is not known; abnormal persistent skin inflammation, overheating caused by dressings, local sensitizers, 33 and systemic opioids are potential contributors. 24 Management should start with a thorough history to identify the timing and exacerbating factors. Occasionally, changing the topical routine (discontinuation of dressings or topical antibiotics) may be sufficient. Itching at night may be related to body overheating and treated with sedating antihistamines (hydroxyzine) or a tricyclic with prominent H-1 antihistamine action (doxepin). Daytime pruritus may require a nonsedating antihistamine H-1 blocker (cetirizine, loratadine). Liquid preparations are always preferable as they have a shorter onset of action and are easier to swallow. There are anecdotal reports of successful use of ondansetron or low-dose gabapentin for persistent pruritus. 29 Recommendation 7: recognize and address limitations in activities of daily living. Pain, odor, and mobility limitations have a significant impact on patients with EB and their daily living. The disease burden may include difficulties in performing personal care, engaging in school or employment activities, and increased financial burden. 34 Depression and anxiety are also common 35 and further contribute to social isolation. Fostering independence and safety during activities of daily living requires environmental modifications (special beds, seating in baths, wheelchairs, footwear). An early rehabilitation consult with frequent reevaluations is recommended. Recommendation 8: provide education and support to the patient/parent and circle of care to increase treatment adherence. Development ; re-evaluate; and edge). We propose using this paradigm for patients with EB (by eliminating the undermining and allocating suffering SU rather than S) in nonhealing wounds for developing a wound care plan and monitoring the response over time. The wound care decision approach should consider the wound location, need for extra padding and protection, specialized dressings, and feasibility for everyday use (Tables IV to VI) .
Recommendation 10: gently cleanse wounds with low-toxicity solutions. The standard of care for wound cleansing is to use solutions that are gentle and noncytotoxic. 38 For patients with EB we recommend gentle cleansing with a saline solution, water, or dermol 500 (containing benzalkonium chloride 0.1%, 39 Bathing facilitates cleansing, nontraumatic dressing removal, and supplemental antibacterial control (using diluted acetic acid or bleach) and is better tolerated than showering. 32 Recommendation 11: blister management and gentle debridement of eschar/slough. New blister formation is the hallmark of EB. To prevent blister extension we recommend puncturing it (at multiple sites to facilitate optimal drainage) with a sterile needle to release the inner fluid. The overlying skin is left in place, acting as a biological dressing, reducing pain, and minimizing infection risk. A firm dehydrated eschar or soft slough requires debridement to remove senescent cells that are deficient in cellular activities and biofilms that maintain the inflammatory process. 40 Debridement in the EB population should, whenever possible, involve nonphysical methods (hydrogel, calcium alginate dressings).
Recommendation 12: assess and treat critical colonization, infection, and abnormal inflammation. Inflammation or infection impairs normal healing. The difference between colonization and infection is the interplay between the number and type of colonies and host resistance. 41 In bacterial colonization, bacterial colonies do not interfere with healing. Critical colonization occurs when the bacterial proliferation causes local damage and wounds get ''stuck'' precluding healing. Surface critical colonization and deep and surrounding skin infection are clinical diagnoses. The mnemonics NERDS (nonhealing; increased exudate; red, friable tissue; debris, dead slough; smell) and STONEES (increased size; temperature [38F warmer than contralateral skin; os, exposed/probing to bone; new areas of breakdown; erythema/edema of surrounding skin; increased exudate and smell) 42, 43 represent the two levels of superficial bacterial damage or deep and surrounding skin infection and have been validated for use in chronic wounds. Any 3 NERDS criteria are indicative of superficial critical colonization and require a topical antimicrobial. Three or more criteria from STONEES suggest deeper/surrounding skin infection and need for systemic therapy. Although these concepts need to be validated for EB, more than 3 criteria are useful to distinguish infection from persistent inflammation. The most common bacteria isolated from chronic and most likely EB wounds are gram-positive organisms (Staphylococcus aureus and Streptococci species), gram negatives (Pseudomonas aeruginosa), and anaerobes (R. G. Sibbald, MD, oral communication, July 2012). As such, documentation of critical colonization/infection in the EB population is rarely needed and skin swabs are indicated only to determine antibiotic selection in cases of multiresistant organisms or nonresponsive infection. Critical colonization can be controlled with topical agents. The bacterial load may be reduced by bathing with diluted bleach, applying compresses, or using sprays with diluted vinegar. 39 Lipid-stabilized hydrogen peroxide cream (Crystacide, DermaUK, Stotfold, UK) is well tolerated and effective when applied directly on the wound or contact dressing. 39 Topical antibiotics/antimicrobials (eg, polymyxin Bgramicidin, fusidic acid, mupirocin, silver sulfadiazine) should be used only for short periods of time and rotated every 2 to 6 weeks to prevent resistance and sensitization. 39 When using these agents, we recommend applying them on the dressing rather than directly on the skin to limit pain and trauma. Other options include dressings containing silver, honey, iodine, and polyhexamethylene biguanide (Table V) . 44 Silver has broad-spectrum antimicrobial activity and must be ionized to exert maximum effect. Ionized silver requires an aqueous or water environment. 44 High serum levels of silver have been documented in patients with EB who use silver dressings (J. Mellerio, MD, oral communication, July 2011); therefore, their prolonged use over large surface areas should be discouraged. Medical-grade honey products (ointments, dressings) may provide short-term benefit, but their use can increase local pain and may temporarily increase exudate levels. 39 The use of antimicrobial dressings should be reviewed at regular intervals, and discontinued if critical colonization has been corrected or if there is no beneficial effect.
Signs of deep and surrounding tissue infection (lymphadenopathy, fever, and malaise) require systemic antimicrobial therapy. Empirical use of systemic antibiotics that cover common pathogens is recommended. The antibiotic choice can be further refined based on identified pathogenic organisms and their antimicrobial sensitivities. Streptococcus pyogenes presence requires treatment even in the absence of overt clinical infection because of risk of complications. For chronic nonhealing wounds, long-term, alternating, low-dose antibacterial agents (trimethoprim, macrolides, doxycycline) may be beneficial for their anti-inflammatory effects.
Recommendation 13: select a dressing/topical therapy that is appropriate for the needs of the patient and the caregiver based on the subtype of EB. Dressing choices should be individualized based on EB subtype, extent and wound location, dressing frequency, cost, and availability (Tables IV to VI) . Wound healing requires an appropriate wound surface moisture balance. This is achieved by using dressings with occlusive, semiocclusive, absorptive, hydrating, and hemostatic characteristics, depending on the wound characteristics and drainage (Tables IV to VI). Another consideration for the EB population is management of chronic wounds. Chronic wounds are often stalled in the inflammatory stage. 44 These wounds demonstrate marked increased activity of inflammatory cells and associated mediators such as matrix metalloproteinase and elastase, 44 responsible for degradation of extracellular matrix and growth factors that hinder progression toward re-epithelialization. 45 Combined local and systemic intervention may be required to facilitate wound healing (recommendation 12).
Recommendation 14: evaluate the expected rate of healing or reassess wound goals of care (including potential maintenance status). A wound size reduction of 20% to 40% in 2 and 4 weeks is quoted to be a reliable predictor of healing at 12 weeks. [46] [47] [48] In addition, clinical observation of the edge of the wound is foretelling: nonhealing wounds often have a ''cliff edge'' instead of the purple ''tapered sandy shore beach'' of healable ones. If the wound edge is not advancing after appropriate wound-bed preparation, advanced therapies should be considered 49 after all causes of delayed healing have been ruled out (SCC). Complete healing may not be an achievable goal in EB. Other wound-related outcomes such as pain reduction, decreased bacterial load, and need for dressing changes, or increased quality of life are more attainable.
Recommendation 15: edge effecteif a wound is stalled, the edge or other areas appear atypical; consider a skin biopsy to rule out SCC or other complications before considering active therapeutic options. The cumulative risk of developing SCC in severe generalized RDEB by age 55 years is 90% 8 representing a major cause of morbidity and mortality. 11 They tend to occur much earlier in the EB population, are multifocal, and more aggressive. As wound chronicity is the norm in many patients with EB, a high degree of suspicion is required. Biopsy of wounds that enlarge rapidly, have increased pain, change in appearance on serial photographic documentation, or ''feel different'' is recommended. 50 Develop individualized goals and plan of care Recommendation 16: develop and reassess tailored plan of care. A comprehensive assessment should result in an individualized wound care plan tailored to the individual, taking into consideration unique biopsychosocial needs (Table VII) . Patient preference must be respected and reflected in the wound care plan. 51 It is common for EB families to have time-tested routines that do not necessarily follow the currently accepted medical wisdom. A flexible approach will most likely increase adherence, increase satisfaction with care, and lead to improved outcomes. With the new, disease-modifying cellular therapies that are currently emerging, 52 it is also important to maximize the chances of each patient being a potential candidate for these therapies (Table VIII) . The wound care plan should be clearly outlined in a written document given to the family and copied to the family practitioner and home-care personnel. The care plan should also be evaluated and updated regularly.
Provide organizational support
Recommendation 17: consider a health care system support structure including specialized nurses, interprofessional clinics, and a structured approach to new cases. EB is not just a skin disorder; therefore treating a patient with EB requires involvement of a dedicated team with expertise in all aspects of care. Over the past decade specialized EB clinics have opened in 16 countries worldwide, providing an interprofessional model of care with input from many allied health professionals (eg, nurses, physicians, surgeons, occupational therapists, physical therapists, social workers, dietitian, music therapists). [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] Isolated cases can be overwhelming to health practitioners particularly when referral to an established EB center is not feasible. Access to international EB experts via http://www. internationalebforum.org is possible and has changed the fabric of pre-existing professional isolation. Other resources for patients and practitioners are DEBRA foundations that exist in many countries.
The birth of a child with EB is a traumatic event for a family. We have found that early education about the disease, determining the type/subtype of EB as soon as possible, and providing ongoing support from knowledgeable practitioners allows a family to regroup and focus on providing the best care to their baby.
DISCUSSION
EB is one of the most complex diseases in medicine, with severe EB types having devastating effects on the quality of life and life span of affected patients. Until a cure is available, anticipatory guidance for possible disease-related complications and appropriate wound care are the cornerstones of EB management. EB is a prototype of an orphan disease. Although rare, its severity combined with little evidence for clinical practice leads to suboptimal patient care and practitioner isolation. Practice guidelines (systematic statements that assist physician in decision making) 68 are increasingly recognized as tools that reduce inappropriate care, control geographic variation, and make use of best health care resources. 69 To date there is no randomized controlled trial scientific evidence for any of the health care interventions that we use in these patients. To our knowledge, this is the first attempt to develop guidelines of care for the EB population that focus on wound care, with a holistic approach that takes into account other patient-related factors, patient preferences, and the immediate and extended care teams. We have brought together experts in the fields of EB, wound care biology, and clinical practice to provide the best available approaches to optimize wound care in patients with EB. The next step is to seek further consensus on specific statements that make up each recommendation. These 
